The Asia Pacific Patient-controlled Analgesic Pumps Market would witness market growth of 11% CAGR during the forecast period (2021-2027). There are various painful conditions in which patient-controlled analgesic pumps are proved to be effective and they are mainly beneficial in acute postoperative pain management.
Unique patient-controlled analgesic treatment like PCRA, PCEA, and noninvasive methods of PCA has increased the alternatives for pain-relief treatment. Along with this, the adoption of these methods would be fueled in the next few years due to the developments in PCA technology such as variable-rate infusions that are evaluated on the basis of patient requirements for analgesia and better patient monitoring.
The growth of the market would be supplemented by the integration of the latest technologies in PCA pumps that assists in the quick pain recovery and hence, encourage patients to opt for this device. For example, Acromed Chroma infusion pumps incorporate the new technology in pain management that enables patients to deliver bolus analgesic medicine themselves. This empowers patients to get relief from the pain and enables them to feel comfortable while reducing the requirement for on-site support from hospital members.
The China market dominated the Asia Pacific Specialty Clinics Market by Country in 2020, thereby, achieving a market value of $10,754.7 Thousands by 2027, growing at a CAGR of 8.2% during the forecast period. The Japan market is exhibiting a CAGR of 11.5% during (2021 - 2027). Additionally, The India market is anticipated to witness a prominent CAGR during (2021 - 2027).
Based on Type, the market is segmented into Electronic and Mechanical. Based on Application, the market is segmented into Oncology, Diabetes, Hematology, Gastroenterology and Others. Based on End-use, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Patient-Controlled Analgesic Pumps Market is Projected to reach USD 614.5 Million by 2027, at a CAGR of 9.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smiths Group PLC, Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Terumo Corporation, Abbott Laboratories, Avante Health Solutions, ICU Medical, Inc., and Ace Medical Co., Ltd.
By Type
By Application
By End Use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
